Meeting
2022 ASCO Quality Care Symposium
Academic and community physician perspectives on breast cancer biomarker use in clinical trials.
Authors
Halle H. Thannickal
University of Alabama at Birmingham, Birmingham, AL
Halle H. Thannickal, Noon Eltoum, Courtney J. Andrews, Rachel Marie Frazier, Lynne I. Wagner, Lauren P. Wallner, Antonio C. Wolff, Gabrielle Betty Rocque
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Quality Improvement Research and Implementation Science
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 349)
DOI
10.1200/JCO.2022.40.28_suppl.349
Abstract #
349
Poster Bd #
D22
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
EDEN (Etude Désescalade sEmiNome): Prospective therapeutic de-escalation and miRNA-M371 biomarker evaluation phase II study for stage IIa/IIb < 3 cm seminomas.
First Author: Armelle Vinceneux
Poster
2022 ASCO Quality Care Symposium
“It sounds very negative”: Patient perspectives on de-escalation of treatment concept and language.
First Author: Courtney J. Andrews
Poster
2021 ASCO Annual Meeting
Association of changes of pro-inflammatory markers with physical function in women with breast cancer receiving chemotherapy.
First Author: Nikesha Gilmore
Poster
2020 ASCO Quality Care Symposium
Effects of COVID-19 on an academic breast oncology center in New York City.
First Author: Jake Prigoff